KalVista Pharmaceuticals, Inc. Quarterly Operating Lease, Liability in USD from Q2 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
KalVista Pharmaceuticals, Inc. quarterly Operating Lease, Liability history and growth rate from Q2 2019 to Q1 2024.
  • KalVista Pharmaceuticals, Inc. Operating Lease, Liability for the quarter ending April 30, 2024 was $7.32M, a 11.1% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $7.32M -$915K -11.1% Apr 30, 2024 10-K 2024-07-11
Q1 2023 $8.23M +$44K +0.54% Apr 30, 2023 10-K 2023-07-10
Q1 2022 $8.19M +$2.28M +38.6% Apr 30, 2022 10-K 2022-07-07
Q2 2021 $7.38M +$5.86M +385% Jul 31, 2021 10-Q 2021-09-09
Q1 2021 $5.91M +$4.26M +259% Apr 30, 2021 10-K 2021-07-13
Q4 2020 $1.72M +$197K +13% Jan 31, 2021 10-Q 2021-03-11
Q3 2020 $1.35M -$301K -18.2% Oct 31, 2020 10-Q 2020-12-10
Q2 2020 $1.52M -$234K -13.3% Jul 31, 2020 10-Q 2020-09-14
Q1 2020 $1.65M Apr 30, 2020 10-K 2020-07-01
Q4 2019 $1.52M Jan 31, 2020 10-Q 2020-03-10
Q3 2019 $1.66M Oct 31, 2019 10-Q 2019-12-03
Q2 2019 $1.76M Jul 31, 2019 10-Q 2019-09-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.